IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Blue Water Life Science Advisors, LP

Q4 2021 Holdings

Filed 2022-02-14 | 13 holdings | $56.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Caredx Inc(CDNA)COM14167L103$38.4M844,97068.1%
Avantor Inc(AVTR)COM05352A100$17.3M410,27030.6%
Better Therapeutics Inc(BTTX)COMMON STOCK08773T104$465.0K100,0000.8%
Natera Inc(NTRA)COM632307104$67.4K722,1810.1%
Thermo Fisher Scientific Inc(TMO)COM883556102$52.2K78,3000.1%
Guardant Health Inc(GH)COM40131M109$39.1K390,9450.1%
Bio-Techne Corp(TECH)COM09073M104$28.3K54,7110.1%
Agilent Technologies Inc(A)COM00846U101$26.8K168,1500.0%
Akoya Biosciences IncCOM00974H104$26.2K1,710,8070.0%
Ginkgo Bioworks Holdings Inc(DNA4EUR)CL A SHS37611X100$14.4K1,729,7910.0%
Danaher Corporation(DHR)COM235851102$10.3K31,4000.0%
Somalogic Inc(SLGCUSD)CLASS A COM83444K105$4.7K400,9880.0%
Pear Therapeutics IncCLASS A COM704723105$1.2K194,6860.0%